Efficacy and tolerability of bixalomer for treatment of hyperphosphatemia in maintenance hemodialysis patients with poor tolerance to sevelamer: a switching study. - Bixalomer for treatment of hyperphosphatemia in patients with poor tolerance to sevelamer: a switching study (BIXA-SWITCH Study)

Keijukai Healthcare Corporation,Saitama Tsukinomori Clinic0 个研究点目标入组 50 人开始时间: 2013年5月9日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patients with an intestinal blockage 2)Patients suffering from severe astriction or diarrhea continuously 3)Patients who have experienced gastrointestinal tract ulcer or a surgery in the abdomen 4)Patients with liver dysfunction (whose AST or ALT value is more than twice, or T-Bil value is more than 1.5 times higher than the standard level of the hospital they visit), or patients with a severe hepatic disorder such as cirrhosis 5)Patients who are expecting a child, lactating or suspected of pregnancy, or patients who want to be pregnant during their participation in this study 6)Patients considered as ineligible for this study by the investigator for another reason

发起方

Keijukai Healthcare Corporation,Saitama Tsukinomori Clinic